Ablevia biotech GmbH
Back to list
Facts
- Founded
- 2018
- Staff
- 4
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Focus
- human health
Profile
Ablevia develops a new class of infusible therapeutics to selectively remove harmful and disease-causing antibodies. These therapeutics can be readily adapted to target unwanted antibodies in rare diseases or in conditions with unmet clinical needs. Founded in 2018 at the Vienna Biocenter Campus, Ablevia focuses on IP generation and preclinical research and development.
R&D:Ablevia focusses on research and development of therapeutics for the selective removal of disease-causing and harmful anitbodies in autoimmune diseases or neutralizing anti-drug anitbodies.
Similar companies in RDM biotech/pharma
Attoquant Diagnostics GmbH
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Cluster
- LISAvienna
- Focus
- human health
Pharmazeutische Fabrik Montavit GmbH
- Organization type
- RDM biotech/pharma
- Region
- Tyrol
- Cluster
- Life Sciences Tyrol
- Focus
- human health
Eurofins Genomics AT GmbH
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Cluster
- LISAvienna
- Focus
- non-specific applications
Daiichi Sankyo Austria GmbH
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Cluster
- LISAvienna
- Focus
- human health